Calidi Biotherapeutics (CLDI) Tax Provisions (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Tax Provisions of -$16000.0 for Q4 2025, down 633.33% year-over-year from $3000.0 in Q4 2024, and down 260.0% quarter-over-quarter from $10000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Tax Provisions (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at -$16000.0 for Q4 2025.
- In Q4 2025, Tax Provisions fell 633.33% year-over-year to -$16000.0; the TTM figure through Dec 2025 stood at $1000.0 (down 92.86% YoY), while the FY2025 annual figure was $1000.0, down 92.86% from the prior year.
- Tax Provisions for Q4 2025 stood at -$16000.0, down from $10000.0 in the prior quarter.
- The five-year high for Tax Provisions was $11000.0 in Q3 2023, with the low at -$16000.0 in Q4 2025.
- The 4-year median for Tax Provisions is $3500.0 (2023), against an average of $2071.4.
- Peak annual rise in Tax Provisions reached 1100.0% in 2025, while the deepest fall reached 633.33% in 2025.
- Calidi Biotherapeutics' Tax Provisions stood at -$3000.0 in 2022, then changed by 0.0% to -$3000.0 in 2023, then surged by 200.0% to $3000.0 in 2024, then sank by 633.33% to -$16000.0 in 2025.
- Business Quant data shows CLDI's Tax Provisions at -$16000.0 in Q4 2025, $10000.0 in Q3 2025, and $4000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 1,000.00 |